Lymphoma Trial, Recruiting NCT04575883 Sponsor: University of Alberta Condition: Lymphoma
Back to Lymphoma

Lymphoma Trial, Recruiting

NCT04575883
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 10 and 18 years old
  • You have had surgery to repair a moderate to complex congenital heart defect (a heart condition you were born with)

Who may not be able to join:

  • You do not speak English, as communication during the exercise sessions is required
  • Your home does not have enough space to fit the exercise bike system used in the trial
  • You have previously taken part in a cardiac rehabilitation or structured exercise program
  • Your heart doctor has told you not to exercise or has advised against taking part
  • A previous exercise stress test showed heart rhythm problems, unusual changes in heart activity, blood pressure that did not rise enough during exercise or went above 200 mmHg, or you experienced chest pain or fainting during the test (confirm with trial site)
  • Your blood oxygen level at rest is below 85%, or you need oxygen support
  • Your most recent heart scan (echocardiogram) showed at least moderate problems with how well your heart pumps
  • You have a history of chest pain during exercise
  • Your congenital heart condition has not yet been repaired or treated with surgery
  • You have had heart rhythm problems in the last year, such as certain types of irregular or abnormally fast heartbeats, or a specific type of heart block (confirm with trial site)
  • You have noticeable symptoms affecting your daily activities due to your heart condition (confirm with trial site)
  • You currently have another illness that would prevent you from taking part
  • You have a cognitive (thinking or learning) difficulty that would make it hard to communicate during the exercise sessions
  • You have another physical condition, unrelated to your heart, that limits your ability to exercise

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Michael Khoury, MD, University of Alberta

Phone: 7804077499

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
22 November 2022
Est. completion
31 July 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Exercise capacity in the change in VO2peak (mL/kg/min) measured through CPET testing

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov